Menopause can affect bladder control in several ways, from changes in estrogen-sensitive tissues to shifts in pelvic floor support and muscle function. Understanding whether your symptoms are caused by stress incontinence, overactive bladder, or a combination can help you choose a treatment that matches the problem.
Updated: August 15, 2026
Author: Elidah Medical Staff
Bladder leaks are common in women, and they can become more noticeable during and after menopause. However, menopause is not usually the only reason they develop.
Estrogen affects tissues throughout the vagina, urethra, and lower urinary tract. As estrogen levels decline, these tissues can become thinner, drier, and less resilient. Menopause-related genitourinary changes can contribute to urinary urgency, frequency, discomfort, and recurrent urinary tract infections.
At the same time, the muscles and connective tissues that help support the bladder and urethra can change with age. Pregnancy and childbirth history, weight, constipation, chronic coughing, medications, and previous pelvic surgery may also affect bladder control.
This is why treating menopause-related bladder problems starts with identifying what type of urinary incontinence you have, rather than assuming all leaks have the same cause.
If you are still in the years leading up to menopause and have recently noticed changes in your bladder, see our guide to perimenopause symptoms and bladder problems.
Urinary incontinence simply means involuntary urine leakage, but several different conditions can cause it. The three patterns women most commonly encounter are stress urinary incontinence, urge incontinence, and mixed incontinence.
Stress urinary incontinence causes leakage when pressure is placed on the bladder, such as during coughing, sneezing, laughing, lifting, running, or exercise.
Urge incontinence is leakage associated with a sudden, difficult-to-control need to urinate. It commonly occurs as part of overactive bladder, which may also cause frequent urination and nighttime bathroom trips.
Mixed incontinence means experiencing both stress and urge symptoms. For example, you may sometimes leak when you sneeze but at other times leak because you cannot reach the bathroom quickly enough.
The easiest way to begin distinguishing the two is to ask what is happening immediately before you leak. Stress leaks are usually triggered by movement or physical pressure. Urge leaks are preceded by a strong need to urinate.
The difference matters because the treatments are not identical. Stress incontinence treatment often focuses on improving pelvic floor muscle strength and support, while overactive bladder treatment may focus more on bladder habits, medications, or the nerves involved in bladder control.
Treatment should match the type of bladder problem you have. Some women need only one approach, while others benefit from combining pelvic floor treatment, bladder training, lifestyle changes, medications, or hormone-related treatment. Mixed incontinence requires attention to both types of symptoms. Elitone is designed to deliver stimulation for pelvic floor strengthening as well as calming signals for urgency, making it particularly relevant when stress and urge symptoms occur together.
| When you notice | Likely type | What’s happening | Treatment direction | Elitone option |
|---|---|---|---|---|
| Leaks with coughing, sneezing, laughing, lifting, or exercise | Stress incontinence | Pressure overcomes support around the urethra | Improve pelvic floor strength and urethral support | Elitone |
| Sudden strong urge, frequent urination, or leaking before reaching the bathroom | Urge incontinence / OAB | Bladder and nerve signaling trigger urgency or unwanted bladder contractions | Calm urgency and improve bladder control | Elitone URGE |
| Both activity-related leaks and sudden urgency | Mixed incontinence | Both stress and urgency mechanisms are present | Address both pelvic floor support and urgency pathways | Elitone |
Pelvic floor muscle training is a common first-line treatment for stress urinary incontinence. These muscles help support the bladder and urethra and need to contract at the right time when pressure increases during coughing, sneezing, lifting, or exercise.
Traditional Kegel exercises can help, but they require correct technique and consistent practice. Some women have difficulty identifying the right muscles or maintaining a regular exercise routine.
Elitone is an FDA-cleared, external treatment for stress and mixed incontinence. It uses gentle electrical muscle stimulation to activate the pelvic floor through the skin (and some signals to calm OAB), producing 100 contraction and rest cycles during each 20-minute treatment. Because it is worn externally, treatment does not require anything to be inserted vaginally.
When the main problem is sudden urgency, frequent urination, or leaking before reaching the bathroom, treatment may focus on bladder control rather than pelvic floor strengthening alone.
Common approaches include bladder training, adjusting fluid timing, reducing bladder irritants when they worsen symptoms, treating constipation, medications, and nerve-based therapies.
Elitone Urge is an FDA-cleared, external treatment for urinary urgency and overactive bladder. It works by stimulating nerves involved in bladder control rather than focusing primarily on pelvic floor muscle contractions.
Women with mixed symptoms may need to address both stress leakage and urgency. Elitone (regular) sends out signals for both contractions and relaxation to address mixed incontinence.
Hormone treatment can improve some genitourinary symptoms of menopause, but it is important to distinguish between local vaginal estrogen and systemic hormone replacement therapy.
Local vaginal estrogen may help symptoms associated with genitourinary syndrome of menopause, including vaginal dryness, urinary discomfort, urgency, and recurrent urinary tract infections in appropriate women.
Systemic hormone replacement therapy is primarily used for symptoms such as hot flashes and night sweats. It is not considered a primary treatment for urinary incontinence, and systemic estrogen does not consistently improve bladder leakage.
For a fuller discussion of benefits, risks, and the different forms of hormone therapy, see our guide to hormone replacement therapy during menopause.
Simple changes can sometimes reduce bladder symptoms, especially when combined with a treatment directed at the underlying type of incontinence.
If menopause-related weight changes are making bladder symptoms harder to manage, see our guide to menopause and weight gain.
Bladder leakage is common, but it should not automatically be dismissed as a normal part of menopause or aging. A healthcare provider can help identify the type of incontinence and rule out other causes.
Seek medical evaluation if you have blood in the urine, pain or burning with urination, difficulty emptying your bladder, recurrent urinary tract infections, pelvic pain, or a sudden major change in urinary habits.
Even when there are no warning signs, it is worth discussing symptoms if they are limiting exercise, travel, sleep, social activities, or confidence. The earlier the pattern is identified, the easier it is to match treatment to the problem.
Menopause can contribute to bladder and urinary changes, but it is usually not the only cause of incontinence. Declining estrogen can affect tissues in the vagina, urethra, and lower urinary tract, while age, childbirth history, pelvic floor weakness, weight, medications, and other health conditions can also play a role.
Stress urinary incontinence and overactive bladder are both common in midlife and older women. Stress incontinence causes leaks with coughing, sneezing, laughing, lifting, or exercise. Overactive bladder causes sudden urgency, frequent urination, and sometimes urge leakage. Some women have both, which is called mixed incontinence.
Pelvic floor muscle training can help stress urinary incontinence by improving the strength and coordination of the muscles that support the bladder and urethra. The exercises need to be performed correctly and consistently to be effective.
Local vaginal estrogen may improve certain urinary and vaginal symptoms associated with genitourinary syndrome of menopause, including urgency and recurrent urinary tract infections in appropriate women. Systemic hormone replacement therapy is not considered a primary treatment for urinary incontinence.
Treatment commonly starts with pelvic floor muscle training and other conservative options. Depending on symptom severity, additional treatments may include external electrical muscle stimulation, pessaries, urethral support devices, or surgery. The right choice depends on the severity of leakage, personal preferences, and medical history.
Yes. Bladder training, changes in fluid timing, treatment of constipation, pelvic health strategies, and nerve-based therapies may help reduce urgency and frequency. Medication is one option, but it is not the only treatment available.
The Menopause Society. Menopause Symptoms. Accessed August 2026.
The Menopause Society. Genitourinary Syndrome of Menopause. Accessed August 2026.
American Urological Association, Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction, and American Urogynecologic Society. Genitourinary Syndrome of Menopause Guideline. 2025.
National Institute of Diabetes and Digestive and Kidney Diseases. Symptoms & Causes of Bladder Control Problems. Accessed August 2026.
National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for Bladder Control Problems. Accessed August 2026.
Receive educational resources, exclusive offers, and new product information.
